Teclistamab in patients with multiple myeloma and impaired renal function

被引：11
|
作者：
Joiner, Laura [1 ]
Bal, Susan [2 ]
Godby, Kelly N. [2 ]
Costa, Luciano J. [2 ,3 ]
机构：
[1] Univ Alabama Birmingham, Dept Pharm, Birmingham, AL USA
[2] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA
[3] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, 1802 6th Ave South, Birmingham, AL 35294 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 11期
关键词：
D O I：
10.1002/ajh.27063
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E322 / E324
页数：3
相关论文
共 50 条
  • [31] Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function
    Nozza, Andrea
    Siracusano, Licia
    Armando, Santoro
    CLINICAL THERAPEUTICS, 2006, 28 (06) : 953 - 959
  • [32] Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma
    Davis, James A.
    Snyder, Jordan
    Rice, Mikhaila
    Moore, Donald C.
    Cahoon, Christopher
    Julian, Kelley
    Wagner, Charlotte B.
    Granger, Katelynn
    Green, Kimberly M.
    Atrash, Shebli
    Hill, Hailey
    Mcelwee, Jessica
    Elsey, Grace
    Khouri, Jack
    Rudoni, Joslyn
    Mahmoudjafari, Zahra
    Nachar, Victoria R.
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [33] A Real-World Analysis of the Safety and Efficacy of Teclistamab for Patients with Relapsed/Refractory Multiple Myeloma and Baseline Renal Impairment
    Habib, Alma
    Khan, Abdullah Mohammad
    Laharwal, Mehak M.
    Mewawalla, Prerna
    Mckenna, Marshall
    Tiger, Yun Kyoung
    Shaikh, Hira
    Strouse, Christopher
    Green, Kimberly M.
    Davis, James A.
    Hashmi, Hamza
    Snyder, Jordan
    Mahmoudjafari, Zahra
    Mushtaq, Muhammad Umair
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Atrash, Shebli
    Paul, Barry
    Friend, Reed
    BLOOD, 2024, 144 : 7037 - 7038
  • [34] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
    Cohen, Yael C.
    Magen, Hila
    Gatt, Moshe
    Sebag, Michael
    Kim, Kihyun
    Min, Chang-Ki
    Ocio, Enrique M.
    Yoon, Sung-Soo
    Chu, Michael P.
    Rodriguez-Otero, Paula
    Avivi, Irit
    Quijano Carde, Natalia A.
    Kumar, Ashwini
    Krevvata, Maria
    Peterson, Michelle R.
    Di Scala, Lilla
    Scott, Emma
    Hilder, Brandi
    Vanak, Jill
    Banerjee, Arnob
    Oriol, Albert
    Morillo, Daniel
    Mateos, Maria-Victoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02): : 138 - 149
  • [35] Outpatient Management of CAR-T and Teclistamab for Patients with Lymphoma and Multiple Myeloma
    Bansal, Radhika
    Paludo, Jonas
    Corraes, Andre
    Spychalla, Megan
    Haugen, Kelsey
    Khurana, Arushi
    Hampel, Paul J.
    Durani, Urshila
    Dingli, David
    Hayman, Suzanne R.
    Kapoor, Prashant
    Wang, Yucai
    Binder, Moritz
    Kenderian, Saad S.
    Kourelis, Taxiarchis
    Kumar, Shaji Kunnathu
    Warsame, Rahma M.
    Bennani, N. Nora
    Gertz, Morie A.
    Johnston, Patrick B.
    Ansell, Stephen M.
    Lin, Yi
    BLOOD, 2023, 142
  • [36] Dexamethasone for the Management of CRS Related to Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma
    Davis, James A.
    Snyder, Jordan
    Rice, Mikhaila
    Moore, Donald C.
    Cahoon, Christopher
    Julian, Kelley
    Wagner, Charlotte B.
    Granger, Katelynn
    Green, Kimberly M.
    Atrash, Shebli
    Hill, Hailey
    Mcelwee, Jessica
    Elsey, Grace
    Khouri, Jack
    Rudoni, Joslyn
    Mahmoudjafari, Zahra
    Nachar, Victoria
    BLOOD, 2024, 144 : 2382 - 2383
  • [37] Inpatient vs Outpatient Use of Teclistamab in Multiple Myeloma
    Chari, Ajai
    Callander, Natalie
    Pianko, Matthew James
    Schmidt, Timothy
    Landgren, C. Ola
    Costello, Caitlin
    ONCOLOGY-NEW YORK, 2024, 38 (02):
  • [38] Assessment of renal function in patients with multiple myeloma: the role of urinary proteins
    A. Corso
    G. Serricchio
    P. Zappasodi
    C. Klersy
    T. Bosoni
    R. Moratti
    C. Castagnola
    M. Lazzarino
    G. Pagnucco
    C. Bernasconi
    Annals of Hematology, 1999, 78 : 371 - 375
  • [39] Assessment of renal function in patients with multiple myeloma: the role of urinary proteins
    Corso, A
    Serricchio, G
    Zappasodi, P
    Klersy, C
    Bosoni, T
    Moratti, R
    Castagnola, C
    Lazzarino, M
    Pagnucco, G
    Bernasconi, C
    ANNALS OF HEMATOLOGY, 1999, 78 (08) : 371 - 375
  • [40] Rapid Improvement in Renal Function in Patients with Multiple Myeloma and Renal Failure Treated with Bortezomib
    Qayum, Abdul
    Aleem, Aamer
    Al Diab, Abdel Rehman
    Niaz, Faraz
    Al Momen, Abdel Karim
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2010, 21 (01) : 63 - 68
12345